Diabetes PubMed

  • Increase font size
  • Default font size
  • Decrease font size
Home Lifestyle

Lifestyle

Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the juvenile diabetes research foundation continuous glucose monitoring randomized trial

Individuals who use continuous glucose monitoring (CGM) on a near-daily basis can have substantial improvement in glycemic control.
Read more...
 

Practical Considerations in the Use of Real-Time Continuous Glucose Monitoring Alerts

Real-time continuous glucose monitoring (CGM) is safe and generally well tolerated; however, individualization of alert settings is necessary maximize the system's benefits and patient adherence.
Read more...
 

Insufficient long-term glycemic control is associated with multifocal ERG defects in adolescents with Type 1 Diabetes

Poor long-term glycemic control is associated with an increase in areas of localized neuro-retinal dysfunction in adolescents with T1D and no clinically-visible diabetic retinopathy (DR).
Read more...
 

Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia

Current evidence suggests that intensive glycemic control should be initiated as soon as possible after diagnosis of type 1 or type 2 diabetes in order to maximize potential long-term macrovascular benefits.
Read more...
 

Blood glucose control and coronary heart disease

Results of recent large-scale intervention trials, such as ACCORD, ADVANCE, and VADT, seem to undermine the concept that tight glycemic control confers some protection against cardiovascular disease in patients with type 2 diabetes, while maintenance of near-normal glycemic control from earlier stage of the disease and during acute coronary events seems to be more beneficial.
Read more...
 

Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: A meta-analysis

An intensive glucose control strategy can effectively reduce the risk of major cardiovascular events but at the expense of a significantly increased risk of severe hypoglycemia in patients with type 2 diabetes.
Read more...
 

Lessons learned from glycemia control studies

A series of recent studies provide further insight and show that intensive glycemic control in type 2 diabetic patients does provide macrovascular benefit but is associated with increased risk of hypoglycemia. In the critically ill patient, tight glycemic control could be detrimental; thus, a less aggressive glycemic target of 140 to 180 mg/dL is preferred.
Read more...
 

Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus

Developing effective strategies to improve blood glucose control in youth with type 2 diabetes mellitus is essential to prevent or limit the development and progression of atherosclerotic cardiovascular disease.
Read more...
 

Long-term glucose control and risk of perioperative complications

This suggests that poor long-term glucose control may not play a major role in determining short-term surgical morbidity.
Read more...
 

Prevalence of and risk factors associated with diabetic retinopath in pre-diabetic and diabetic population in Shanghai community

Bad blood glucose control and long diabetes duration both increased occurrence of DR (diabetic retinopathy).
Read more...
 

Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes

Nighttime blood glucose control is the biggest challenge and concern for parents, and the development of a commercially available overnight CL system may be an important goal.
Read more...
 

Benefits of Continuous Glucose Monitor Use in Clinical Practice

Personal CGM, in a "real world" setting, is able to improve glucose control and reduce the rates of severe hypoglycemia.
Read more...
 

Self-monitoring of blood glucose in type 2 diabetes: systematic review

The evidence suggested that self-monitoring of blood glucose (SMBG) is of limited clinical effectiveness in improving glycaemic control in people with T2DM on oral agents, or diet alone, and is therefore unlikely to be cost-effective. SMBG may lead to improved glycaemic control only in the context of appropriate education - both for patients and health-care professionals - on how to respond to the data, in terms of lifestyle and treatment adjustment.
Read more...
 

Continuous glucose monitor shows potential for early hypoglycemia detection in hospitalized patients

Data from the CGMS iPro Recorder illustrate the potential benefit of using a real-time CGM in the hospital to detect hypoglycemia in a more timely fashion compared to infrequent point-of-care glucose meter measurements.
Read more...
 

Comparison in the Performance of Glucose Meters in Blood Glucose Monitoring during Pregnancy

The performance of four study glucose meters appeared very similar.
Read more...
 

Recent Applications of Peanut Phytoalexins

In addition to their use as antioxidants and antimicrobials, peanut phytoalexins may possess beneficial health effects. Studies have shown these compounds to have anti-diabetic, anticancer, and vasodilatory effects.
Read more...
 

Fish oils for cardiovascular disease: Impact on diabetes

Nutritional interventions that incorporate functional foods, such fish oils - in particular n-3 polyunsaturated fatty acids (n-3 PUFAs) - may be a novel strategy to reduce insulin insensitivity, dyslipidemia, hypertension and pro-inflammatory state.
Read more...
 

African Americans May Have to Consume More Than 12 Grams a Day of Resistant Starch to Lower Their Risk for Type 2 Diabetes

The results of this study suggest that African Americans may need to consume more than 12 g/day of resistant starch (RS) to lower their risk for type 2 DM.
Read more...
 

Red and Processed Meat Consumption and Risk of Incident Coronary Heart Disease, Stroke, and Diabetes Mellitus. A Systematic Review and Meta-Analysis

Consumption of processed meats, but not red meats, is associated with higher incidence of coronary heart disease (CHD) and diabetes mellitus.
Read more...
 

Fructose and metabolic diseases: New findings, new questions

Consumption of sweetened beverages is however clearly associated with excess calorie intake, and an increased risk of diabetes and cardiovascular diseases through an increase in body weight. This has led to the recommendation to limit the daily intake of sugar calories.
Read more...
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  Next 
  •  End 
  • »


Page 1 of 6

Bookmark and Share

Popular Diabetes PubMed Citations

Newsflash

Millions unite for diabetes awareness on World Diabetes Day 2010
Starting today, people from all corners of the world are uniting together for three days of celebration to put diabetes firmly in the public spotlight. World Diabetes Day is the best opportunity there is to draw attention to the silent killer that is diabetes.
 
Bristol-Myers Squibb Foundation Launches $100 Million Initiative
The Bristol-Myers Squibb Foundation announced Together on Diabetes®: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office - in their homes and communities - and for the course of their disease.
 
New global survey reveals more than one in three patients fail to take insulin as prescribed
More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77% of physicians estimate that in reality this number could be as high as six doses*, according to the Global Attitudes of Patients and Physicians in Insulin Therapy (GAPPTM) survey, released today by Novo Nordisk.
 

Facebook Page Twitter Subscribe to Latest Diabetes PubMed facts... by Email RSS

Subscribe

Get Diabetes PubMed facts delivered by email. Enter your email address:


Delivered by FeedBurner

Who's Online

We have 6 guests online

Sponsored Links

PharmaNews.eu
PharmaNews.eu - the dynamic European pharmaceutical news engine.
www.pharmanews.eu

Advertise here